Hi red. If fcpg were dead ended with only one avenue to create revenue, I would agree. However fcpg is a public company traded here in the states. There is uncertainty in what the prc govt will do in the future. But the govt has recognized that this specific area of enterprise needs attention yesterday. Western entities would join in the parade to get into the prc in a moment and many have already. It is a matter of diversification and also fcpg to create a business model that presents opportunity for the govt and enterprise system. Today I believe the prc announced that they need further investments into specific areas, healthcare being one. Much like here in the states, the need for control of drugs is ever present. The states use the terms generic and brand name to limit profit. We limit new drugs to only 1 mfg and after 7 yrs or so, everyone can jump on board and costs are dramatically reduced. No we are not the same, but there are similarities. Can you imagine fcpg supplying drugs, a relationship with an insurance company or hospital, and creating for simplicity sakes a Pbm? The street is wide open then. Sorry to ramble on. David
